drugset / Trial / NCT00890565
Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)
RandomizedParallel-groupSingle-blindOther
Summary
This study aims to evaluate the electrocardiogram (ECG) effects of Sancuso® compared to placebo and moxifloxacin in healthy subjects.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-08
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granisetron | Other / unclassified | 10 ug/kg | Other |
| Subject | Granisetron | Other / unclassified | 3.1 mg | Other |
| Subject | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.